Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Biden says world on cusp of some 'real breakthroughs' on cancer

Published 03/03/2021, 07:07 PM
Updated 03/03/2021, 07:11 PM
© Reuters. U.S. President Biden holds bipartisan meeting on cancer legislation at the White House in Washington

By Andrea Shalal

WASHINGTON (Reuters) - U.S. President Joe Biden met with a bipartisan group of lawmakers at the White House on Wednesday to brainstorm ways to accelerate the fight against cancer, saying he believed the world was nearing some "real breakthroughs."

Biden, whose son Beau died of brain cancer in 2015 at age 46, said the battle against cancer was deeply personal for him - and many Americans.

He told reporters before the meeting that cancer or "the C word" remained the most frightening word in the English language.

"We can make significant strides fighting cancer and Alzheimer's and other diseases," he said. "I think we're on the cusp of some real breakthroughs across the board on cancer."

The White House said Biden and Vice President Kamala Harris had a productive, nearly hour-long discussion with the lawmakers, but gave no details on specific priorities or legislative plans.

Participating in the meeting were three Democratic senators - Patty Murray, Dick Durbin and Chris van Hollen, two Republican senators - Roy Blunt and Mike Crapo, and four lawmakers from the House of Representatives.

Many of the lawmakers helped passed the 21st Century Cures Act during the Obama administration, which authorized billions of dollars in funding for the National Institutes of Health for research on cancer and other diseases.

During the Obama administration, Biden oversaw Cancer Moonshot, an initiative aimed at speeding development of cancer treatments. Over $1 billion has been invested in the initiative to date, supporting over 240 research projects and 70 cancer science initiatives, according to the National Cancer Institute.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Biden also founded the Biden Cancer Initiative in 2017 as a way to bring together researchers and share data, but it suspended operations after Biden announced his White House bid in 2019.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.